Monthly Archives: September 2020

SphingoTec, BHR Pharmaceuticals ink agreement for distribution of SphingoTec’s acute care portfolio in the UK and Ireland

BHR specializes in innovative diagnostic solutions for point of care Collaboration focuses on SphingoTec’s proprietary assays for bio-ADM®, penKid® and DPP3 Investigator-initiated study in COVID-19 at Guy’s & St Thomas’ Hospital and King's College Hospital NHS Trust Warwickshire, United Kingdom and Hennigsdorf, Germany, September 29, 2020 - BHR Pharmaceuticals Ltd (“BHR”) and SphingoTec GmbH (“SphingoTec”)…
Read more